OCI | GenomeWeb

OCI

NEW YORK (GenomeWeb News) – Canada's Princess Margaret Cancer Foundation said today that it will use a new C$50 million (US$50.3 million) private donation to fund a research effort that will use genomics, molecular imaging, and tumor biology studies to develop personalized cancer medicine innovat

This story has been updated to include additional information from a US survey on people's attitudes about cost of genetic testing. Originally published June 4.

Two Ontario cancer institutes will use the support to seek biomarkers for colorectal cancer.

Founded in 2000 on technology developed at the Ontario Cancer Institute and University of Toronto, Molecular Templates had difficulty securing add-on funding in its home country following a $1.5 million investment earlier this decade.

Australia's National Health and Medical Research Council has awarded the University of Queensland about US$19.3 million to support it's cancer genome sequencing project aimed at characterizing pancreatic and ovarian cancers.

A team of Ontario researchers has identified a six-gene signature that can help predict non-small cell lung cancer outcomes — and uncovered evidence that there may be thousands of alternative prognostic signatures for the disease.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.